Although CYP3A4 and other CYP enzymes have been implicated in both systemic (by hepatic inactivation) [30–33] and cell-intrinsic [34, 35] drug resistance, their role within the tumor microenvironment has never been studied. This evidence concerns the gene PPIG and neoplasm.